Clinical Trial Update: sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sFOLFOXIRI in advanced gastroesophageal cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Cancer

Drugs mentioned

• sFOLFOXIRI

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Gastro-Intestinal Cancer | Phase 2 | Status: RECRUITING